Vikas Garg, MD
Pain Medicine · Logan, UTNPI 1104852599
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 267 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Medtronic at 35.4% of the total.
Across 267 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$1K
- Relievant Medsystems, Inc.$767
- Abbott$370
- Nevro Corp.$336
- Globus Medical$299
- plus $527 from 13 others
Across 1 payment — averaging $150.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Indivior Inc.$150
What the payments were for
- Travel & lodging$4969%
- Food & beverage$4,85691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 146 | $1,897 |
| Boston Scientific | 57 | $1,156 |
| Relievant Medsystems, Inc. | 8 | $767 |
| Abbott | 2 | $370 |
| Nevro Corp. | 14 | $336 |
| Globus Medical | 18 | $299 |
| SPR Therapeutics, Inc | 1 | $76 |
| Nalu Medical, Inc. | 4 | $68 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Saluda Medical Americas, Inc. | 2 | $58 |
| AbbVie | 3 | $51 |
| Biotronik NRO, Inc. | 1 | $48 |
| Quidel Corporation | 1 | $41 |
| GRT US Holding, Inc. | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $17 |
| Painteq LLC | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,317
- Lamitrode SCS Leads$370
How this compares
$5,352 in reported general payments places this provider in the 65th percentile of 61 pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MovantikNaloxegol Oxalate | 39 | $18,027 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 252 | $9,597 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 295 | $9,103 |
| Xtampza ErOxycodone Myristate | 15 | $7,008 |
| Oxycodone Hcl | 172 | $3,603 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 30 | $3,102 |
| Gabapentin | 168 | $2,897 |
| Buprenorphine Hcl | 46 | $2,672 |
| Fentanyl | 17 | $2,650 |
| Tramadol Hcl | 152 | $1,855 |
| Tizanidine Hcl | 187 | $1,681 |
| Lidocaine | 20 | $1,214 |
| Ondansetron Hcl | 39 | $1,197 |
| Pregabalin | 59 | $1,184 |
| Cyclobenzaprine Hcl | 88 | $1,030 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Redhill Biopharma Inc.Movantik | $13 | $18,02739 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $59 | $7,00815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 61 pain medicine providers in Utah.
Other pain medicine in Logan
- Mark SabinLogan$5K
- Maria SchwartzSalt Lake City$813K
- Jeremy JoyalDraper$170K
- Lynn WebsterSalt Lake City$160K
- Benjamin HumpherysLayton$120K
- Derek HaightDraper$78K
- Jon ObraySt George$24K
- Jason BeckstrandWest Jordan$17K
- Austin AlbrightSalt Lake City$14K
- Jeffrey PenceWest Valley City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.